Beijing Bio-targeting Therapeutics Technology Co., Ltd
Clinical trials sponsored by Beijing Bio-targeting Therapeutics Technology Co., Ltd, explained in plain language.
-
Virus therapy takes on deadly brain cancer
Disease control ENROLLING_BY_INVITATIONThis study tests a modified virus (BioTTT001) injected directly into brain tumors in 30 adults with recurrent high-grade glioma. The goal is to see if it is safe, how it spreads in the body, and whether it can help control the cancer. Participants will receive multiple injections…
Phase: PHASE1, PHASE2 • Sponsor: Beijing Bio-Targeting Therapeutics Technology Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Cancer-Fighting virus trial for breast cancer pulled before it began
Disease control TerminatedThis early-stage trial aimed to test a new virus-based drug called BioTTT001, injected directly into tumors, alongside standard pre-surgery treatment for women with locally advanced breast cancer. The goal was to see if the combination was safe and could shrink tumors. However, t…
Phase: PHASE1 • Sponsor: Beijing Bio-Targeting Therapeutics Technology Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Virus injection takes on Hard-to-Treat cancers in early trial
Disease control ENROLLING_BY_INVITATIONThis early study tests a single injection of a modified virus (BioTTT001) directly into tumors in 12 adults with advanced solid cancers that have not responded to standard treatments. The virus is designed to infect and kill cancer cells while also boosting the immune system. The…
Phase: PHASE1 • Sponsor: Beijing Bio-Targeting Therapeutics Technology Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC